SCHEMBL19435537

SCHEMBL19435537

COc1ccc([N+](=O)[O-])c(O)c1I

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.49
ALDH1A1 P00352 3/20 0.49
GPR35 Q9HC97 1/20 0.46
G6PD P11413 1/20 0.45
CRHBP P24387 1/20 0.45
CRHR2 Q13324 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
LMNA P02545 3/20 0.43
KDM4E B2RXH2 2/20 0.42
POLB P06746 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
ABCB1 P08183 3/20 0.41
ABCC1 P33527 3/20 0.41
EGFR P00533 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40
PRKDC P78527 1/20 0.40
HSD17B10 Q99714 1/20 0.40
JUN P05412 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL68284 0.84 TDP1 (0.53) TDP1ALDH1A1GPR35G6PDCRHBP
SCHEMBL17374969 0.84 ALDH1A1 (0.53) TDP1ALDH1A1L3MBTL1LMNAKDM4E
SCHEMBL1850069 0.81 ALDH1A1 (0.50) TDP1ALDH1A1L3MBTL1LMNAKDM4E
SCHEMBL5322745 0.81 ALDH1A1 (0.50) TDP1ALDH1A1GPR35G6PDCRHBP
SCHEMBL7696511 0.81 TDP1 (0.50) TDP1ALDH1A1GPR35G6PDCRHBP
SCHEMBL2545076 0.79 ALDH1A1 (0.49) TDP1ALDH1A1GPR35G6PDCRHBP
SCHEMBL6816142 0.79 G6PD (0.51) TDP1ALDH1A1GPR35G6PDCRHBP
SCHEMBL9023924 0.77 ALDH1A1 (0.50) TDP1ALDH1A1GPR35L3MBTL1LMNA
SCHEMBL27057185 0.77 ALDH1A1 (0.50) TDP1ALDH1A1L3MBTL1LMNAKDM4E
SCHEMBL8349793 0.77 ALDH1A1 (0.50) TDP1ALDH1A1GPR35L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3241822-B1 URAT1 INHIBITOR NIPPON CHEMIPHAR CO (JP) 2021-03-24 EP disclosed
CN-107108478-B URAT1 inhibitors 日本化学药品株式会社 2020-04-24 CN disclosed
US-10173990-B2 URAT1 inhibitor NIPPON CHEMIPHAR CO., LTD. (JP) 2019-01-08 US disclosed
EP-3241822-A1 URAT1 INHIBITOR Nippon Chemiphar Co., Ltd. (JP) 2017-11-08 EP disclosed
US-20170290795-A1 URAT1 INHIBITOR J-PHARMA CO., LTD. (JP) 2017-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170290795-A1 URAT1 INHIBITOR SLC10A1, XDH, URB2 TDP1 2925/4885ALDH1A1 673/4885GPR35 1302/4885
US-10173990-B2 URAT1 inhibitor SLC10A1, XDH, URB2 TDP1 2901/4885ALDH1A1 672/4885GPR35 1293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.